Discover open access scientific publications

Search, annotate, share and cite publications

Publications by F. Henriksson

Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients From a Swedish Societal Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Related publications

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

International Journal of Medicine and Pharmacy
2014English

Indacaterol/Glycopyrronium Is Cost-Effective Compared to Salmeterol/Fluticasone in COPD: FLAME-based Modelling in a Swedish Population

Respiratory Research
PulmonaryRespiratory Medicine
2017English

Cost-Effectiveness of Ticagrelor 60 Mg in High-Risk Post-Mi Patients From a Dutch Societal Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

PMH30 the Societal Cost of Depression: Evidence From 10,000 Swedish Patients in Psychiatric Care

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Prs44 - Informing the Pathway of Copd Treatment (Impact Study) - Single Inhaler Triple Therapy (Ff/Umec/Vi) Versus Umec/Vi in Patients With Copd: Cost-Effectiveness Analysis From a Societal Perspective in Quebec

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prs46 - Informing the Pathway of Copd Treatment (Impact Study) - Single Inhaler Triple Therapy (Ff/Umec/Vi) Versus Ff/Vi in Patients With Copd: Cost-Effectiveness Analysis From a Societal Perspective in Quebec

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Tiotropium Versus Glycopyrronium in Moderate to Very Severe Chronic Obstructive Pulmonary Disease in Canada, Spain, Sweden, and the UK

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

The Cost Effectiveness Analysis of Indacaterol Versus Tiotropium in a Chinese Medical Cost Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Psy96 - Cost-Effectiveness of Originator Adalimumab in Non-Infectious Intermediate, Posterior and Pan-Uveitis From a Societal Perspective in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy